3. Spita G, Clegg H, Dumitru M, et al. The patients’ perspective. In: Migliori GB, Bothamley G, Duarte R, et al., eds. Tuberculosis (ERS Monograph). Sheffield, European Respiratory Society, 2018 pp. 1–7. 4. Loddenkemper R, Murray JF, Gradmann C, et al. History of tuberculosis. In: Migliori GB, Bothamley G, Duarte R, et al., eds. Tuberculosis (ERS Monograph). Sheffield, European Respiratory Society, 2018 pp. 8–27. 5. Duarte R, Santos JV, Santos Silva A, et al. Epidemiology and socioeconomic determinants. In: Migliori GB, Bothamley G, Duarte R, et al., eds. Tuberculosis (ERS Monograph). Sheffield, European Respiratory Society, 2018 pp. 28–35. 6. Lange C, Migliori GB, eds. Tuberculosis. Sheffield, European Respiratory Society, 2012. 7. Barreira-Silva P, Torrado E, Nebenzahl-Guimaraes, et al. Aetiopathogenesis, immunology and microbiology. In: Migliori GB, Bothamley G, Duarte R, et al., eds. Tuberculosis (ERS Monograph). Sheffield, European Respiratory Society, 2018 pp. 62–82. 8. Zellweger J-P, Sousa P, Heyckendorf J. Clinical diagnosis. In: Migliori GB, Bothamley G, Duarte R, et al., eds. Tuberculosis (ERS Monograph). Sheffield, European Respiratory Society, 2018 pp. 83–98. 9. Tagliani E, Nikolayevskyy V, Tortoli E, et al. Laboratory diagnosis. In: Migliori GB, Bothamley G, Duarte R, et al., eds. Tuberculosis (ERS Monograph). Sheffield, European Respiratory Society, 2018 pp. 99–115. 10. Ruhwald M, Andersen PL, Schrager L. Towards a new vaccine. In: Migliori GB, Bothamley G, Duarte R, et al., eds. Tuberculosis (ERS Monograph). Sheffield, European Respiratory Society, 2018 pp. 343–363. 11. Rendon A, Goletti D, Matteelli A. Diagnosis and treatment of latent tuberculosis infection. In: Migliori GB, Bothamley G, Duarte R, et al., eds. Tuberculosis (ERS Monograph). Sheffield, European Respiratory Society, 2018 pp. 381–398. 12. Bothamley G. What next? Basic research, new treatments and a patient-centred approach. In: Migliori GB, Bothamley G, Duarte R, et al., eds. Tuberculosis (ERS Monograph). Sheffield, European Respiratory Society, 2018 pp. 414–429. 13. Chesov D, Botnaru V. Imaging for diagnosis and management. In: Migliori GB, Bothamley G, Duarte R, et al., eds. Tuberculosis (ERS Monograph). Sheffield, European Respiratory Society, 2018 pp. 116–136. 14. Bhowmik A, Herth FJF. Bronchoscopy and other invasive procedures for diagnosis. In: Migliori GB, Bothamley G, Duarte R, et al., eds. Tuberculosis (ERS Monograph). Sheffield, European Respiratory Society, 2018 pp. 137–151. 15. Caminero JA, Scardigli A, van der Werf T, et al. Treatment of drug-susceptible and drug-resistant tuberculosis. In: Migliori GB, Bothamley G, Duarte R, et al., eds. Tuberculosis (ERS Monograph). Sheffield, European Respiratory Society, 2018 pp. 152–178. 16. Krutikov M, Bruchfeld J, Migliori GB, et al. New and repurposed drugs. In: Migliori GB, Bothamley G, Duarte R, et al., eds. Tuberculosis (ERS Monograph). Sheffield, European Respiratory Society, 2018 pp. 179–204. 17. Caminero JA, Lasserra P, Piubello A, et al. Adverse anti-tuberculosis drug events and their management. In: Migliori GB, Bothamley G, Duarte R, et al., eds. Tuberculosis (ERS Monograph). Sheffield, European Respiratory Society, 2018 pp. 205–227. 18. Olland A, Falcoz P-E, Guinard S, et al. Surgery as a treatment. In: Migliori GB, Bothamley G, Duarte R, et al., eds. Tuberculosis (ERS Monograph). Sheffield, European Respiratory Society, 2018 pp. 228–233. 19. Repossi A, Bothamley G. Pregnancy and the elderly. In: Migliori GB, Bothamley G, Duarte R, et al., eds. Tuberculosis (ERS Monograph). Sheffield, European Respiratory Society, 2018 pp. 263–275. 20. Magis-Escurra C, Carvalho ACC, Kritski AL, et al. Comorbidities. In: Migliori GB, Bothamley G, Duarte R, et al., eds. Tuberculosis (ERS Monograph). Sheffield, European Respiratory Society, 2018 pp. 276–290. 21. Viney K, Wingfield T, Kuksa L, et al. Access and adherence to prevention and care for hard-to-reach groups. In: Migliori GB, Bothamley G, Duarte R, et al., eds. Tuberculosis (ERS Monograph). Sheffield, European Respiratory Society, 2018 pp. 291–307. 22. Alffenaar J-WC, Akkerman OW, Bothamley G, et al. Monitoring during and after treatment. In: Migliori GB, Bothamley G, Duarte R, et al., eds. Tuberculosis (ERS Monograph). Sheffield, European Respiratory Society, 2018 pp. 308–325. 23. Muñoz-Torrico M, Cid S, Galicia-Amor S, et al. Sequelae assessment and rehabilitation. In: Migliori GB, Bothamley G, Duarte R, et al., eds. Tuberculosis (ERS Monograph). Sheffield, European Respiratory Society, 2018 pp. 326–342. 24. Zweijpfenning S, Hoefsloot W, van Ingen J, et al. Nontuberculous mycobacteria. In: Migliori GB, Bothamley G, Duarte R, et al., eds. Tuberculosis (ERS Monograph). Sheffield, European Respiratory Society, 2018 pp. 399–413. 25. Nardell E, Volchenkov G. Transmission control: a refocused approach. In: Migliori GB, Bothamley G, Duarte R, et al., eds. Tuberculosis (ERS Monograph). Sheffield, European Respiratory Society, 2018 pp. 364–380. 26. Casalini C, Matteelli A, Komba A, et al. Opportunities for training and learning. In: Migliori GB, Bothamley G, Duarte R, et al., eds. Tuberculosis (ERS Monograph). Sheffield, European Respiratory Society, 2018 pp. 430–445. 27. Tiberi S, Payen MC, Manika K, et al. Clinical cases. In: Migliori GB, Bothamley G, Duarte R, et al., eds. Tuberculosis (ERS Monograph). Sheffield, European Respiratory Society, 2018 pp. 446–460. Disclosures: None declared. xvi https://doi.org/10.1183/2312508X.10031118